Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnoCare OptoelectronicsTPE:6861 +3.32%66 PB Ratio is 6.23 as of Jul. 23, 2026, which is 136% above its 10-year median of 2.64. GuruFocus rates TPE:6861 with a GF Score™ of 66/100 and a GF Value™ of NT$85.86 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, InnoCare Optoelectronics ranks worse than 84.99% on this metric.
The historical rank and industry rank for InnoCare Optoelectronics's PB Ratio or its related term are showing as below:
TPE:6861'
s PB Ratio Range Over the Past 10 Years
Min: 1.31 Med: 2.64 Max: 12.89
Current: 6.23
During the past 8 years, InnoCare Optoelectronics's highest PB Ratio was 12.89. The lowest was 1.31. And the median was 2.64.
TPE:6861's PB Ratio is ranked worse than 84.99% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs TPE:6861: 6.23
During the past 12 months, InnoCare Optoelectronics's average Book Value Per Share Growth Rate was 5.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 24.90% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of InnoCare Optoelectronics was 55.90% per year. The lowest was 15.30% per year. And the median was 31.70% per year.
Back to Basics: PB Ratio
InnoCare Optoelectronics (TPE:6861) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, InnoCare Optoelectronics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnoCare Optoelectronics PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InnoCare Optoelectronics's PB Ratio distribution charts can be found below:
* The bar in red indicates where InnoCare Optoelectronics's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
InnoCare Optoelectronics (TPE:6861) has a PB Ratio of 6.23 as of Jul. 23, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on InnoCare Optoelectronics and its competitors. This is 136% above median its historical median of 2.64. Over the past decade, InnoCare Optoelectronics' PB Ratio has ranged from 1.31 to 12.89. According to the industry distribution chart, InnoCare Optoelectronics ranks #668 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 85%.
Is InnoCare Optoelectronics' PB Ratio too high?
InnoCare Optoelectronics' current PB Ratio of 6.23 is 136% above median its 10-year median of 2.64. Over the past 10 years, this metric has ranged from a low of 1.31 to a high of 12.89. The Medical Devices & Instruments industry median PB Ratio is 2.02. InnoCare Optoelectronics' value of 6.23 is 208.4% above this industry median. Based on the distribution chart, InnoCare Optoelectronics ranks #668 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, InnoCare Optoelectronics has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, InnoCare Optoelectronics ranks #668 out of 786 companies for PB Ratio. This places InnoCare Optoelectronics in the lower half of its industry. The industry median PB Ratio is 2.02. InnoCare Optoelectronics' value of 6.23 is 208.4% above this benchmark. Historically, InnoCare Optoelectronics' own PB Ratio has ranged from 1.31 to 12.89 over the past decade. While the company's 10-year median is 2.64 vs. the industry median of 2.02, InnoCare Optoelectronics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnoCare Optoelectronics's current PB Ratio of 6.23 is 208.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on InnoCare Optoelectronics and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnoCare Optoelectronics's current PB Ratio is 6.23, which is 136% above median its own 10-year median of 2.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$85.86, compared to a current price of NT$218.00 — trading 153.9% above its estimated fair value. The current PB Ratio is 6.23, which is 136% above median its 10-year median of 2.64 and 208.4% above the Medical Devices & Instruments industry median of 2.02. InnoCare Optoelectronics' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current PB Ratio is 6.23 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?
Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued.
The current stock price of NT$218.00 is trading 153.9% above its estimated GF Value™ of NT$85.86.
GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.
Key valuation signals for TPE:6861:
PB Ratio: 6.23 (136% above median its 10-year median of 2.64)
GF Value™: NT$85.86 vs. price of NT$218.00 (153.9% above fair value)
Industry Position: 208.4% above the Medical Devices & Instruments median (#668 of 786)
No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
66GF Score
Get the complete analysis for TPE:6861
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6861 has been successfully added to your 
